Maybe LL did achieve 50% mortality reduction.
Only
Maybe LL did achieve 50% mortality reduction.
Only reason i think it was more like 25% is because I can't see the FDA letting the trial run if mortality reduction achieved was 50%.
One thousand people die each day in the US. That's 500 per day with a treatment that reduces mortality 50%.
If the LL hit 50 and the FDA said "let it run", it seems to me that the FDA is open to some very severe criticism.
Again I am relying on Dr. Seethamraju comments that the FDA was reviewing the data.
The FDA letting it run on 50 is even more perplexing given the highly unusual facts that the FDA was in there, that Seethamraju knew about it, and Seethamraju revealed the FDA was in there.
The FDA knows, for certain, that Seethamraju is out there.
And the FDA knows, for certain, that Seethamraju will do and say whatever he damn well feels like.
Patterson is a shrinking violet compared to Seethamraju.
So LL is going to hit 50, the FDA is going to let it run, and the FDA expects Seethamraju to sit by quietly and watch?
Seethamraju moved heaven and earth to help his patients when there was zero data, zero preclinical studies, and the FDA did not even believe the drug was relevant.
No way Seethamraju will tolerate not having LL for his patients after it is proven to work!!!
My guess is that the FDA cleared their instructions to CYDY with Seethamraju before the instructions were delivered to CYDY.
Maybe the FDA cajoled Seethamraju with something like, "We have to be true to the mathematics. We have to be sure its not random chance before we treat 10,000 patients."
I can see Seethamraju as susceptible to that argument.
But I have to believe Seethamraju exctracted something from the FDA in return for his agreement.
Seethamraju is certainly not afraid of the FDA.
Question is: Is the FDA afraid of Dr. Seethamraju?
And i think all of this could happen whether mortality reduction is 25% or 50%.
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...
Continue Reading
The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...
Continue Reading
Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...
Continue Reading
Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...
Continue Reading
TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...
Continue Reading
Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...
Continue Reading
In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...
Continue Reading
A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...
Continue Reading
Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...
Continue Reading
Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Albion's Upcoming Capital Raises Albion Enterprise VCT PLC, along with Albion Technology & General VCT PLC and Albion Crown VCT PLC, are gearing up for an exciting opportunity for investors. They have announced plans, pending necessary regulatory approvals, to launch a series of prospectus top-up offers aimed at expanding their ordinary shares in the...
Continue Reading
Progressive Corporation Declares Quarterly Dividend On March 7, 2025, the Board of Directors of The Progressive Corporation (NYSE: PGR) made a significant announcement regarding its commitment to shareholders by declaring a quarterly dividend of $0.10 per common share. This dividend is set to be payable on April 11, 2025, to those shareholders who are on record at the...
Continue Reading
Marine Cabirou Triumphs in UCI Downhill Mountain Bike World Cup 28-year-old Marine Cabirou from France emerged victorious in the Elite Women’s division during the final race of the 2025 UCI Downhill Mountain Bike World Cup held at Mont-Sainte-Anne. Her impressive performance not only marks her second win of the year but also serves as a significant comeback after...
Continue Reading
Azome Therapeutics Partners with NCATS for Novel Research Azome Therapeutics, an innovative drug development company, has recently announced a partnership aimed at investigating a groundbreaking therapy targeting Bronchopulmonary Dysplasia (BPD). This collaboration with the National Center for Advancing Translational Sciences (NCATS) focuses on the preclinical development...
Continue Reading
Teladoc Health Prepares for Third Quarter Financial Results Teladoc Health Inc. (NYSE: TDOC), celebrated as a pioneer in virtual care, is gearing up to announce its financial results for the third quarter of 2025. Investors and the public are eagerly anticipating the release, which is set to take place after the market closes on October 29, 2025. This pivotal moment for...
Continue Reading
